chrX-19360382-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001001671.4(MAP3K15):​c.*367C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000383 in 159,227 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.00052 ( 0 hom. 6 hem. )

Consequence

MAP3K15
NM_001001671.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.60

Publications

0 publications found
Variant links:
Genes affected
MAP3K15 (HGNC:31689): (mitogen-activated protein kinase kinase kinase 15) The protein encoded by this gene is a member of the mitogen-activated protein kinase (MAPK) family. These family members function in a protein kinase signal transduction cascade, where an activated MAPK kinase kinase (MAP3K) phosphorylates and activates a specific MAPK kinase (MAP2K), which then activates a specific MAPK. This MAP3K protein plays an essential role in apoptotic cell death triggered by cellular stresses. [provided by RefSeq, Jul 2010]
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
PDHA1 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • pyruvate dehydrogenase E1-alpha deficiency
    Inheritance: XL, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS2
High Hemizygotes in GnomAd4 at 9 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP3K15NM_001001671.4 linkc.*367C>T 3_prime_UTR_variant Exon 29 of 29 ENST00000338883.9 NP_001001671.3 Q6ZN16-1
PDHA1NM_000284.4 linkc.*729G>A 3_prime_UTR_variant Exon 11 of 11 ENST00000422285.7 NP_000275.1 P08559-1A0A024RBX9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP3K15ENST00000338883.9 linkc.*367C>T 3_prime_UTR_variant Exon 29 of 29 5 NM_001001671.4 ENSP00000345629.4 Q6ZN16-1
PDHA1ENST00000422285.7 linkc.*729G>A 3_prime_UTR_variant Exon 11 of 11 1 NM_000284.4 ENSP00000394382.2 P08559-1

Frequencies

GnomAD3 genomes
AF:
0.000314
AC:
35
AN:
111357
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000653
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000958
Gnomad ASJ
AF:
0.000380
Gnomad EAS
AF:
0.000283
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000168
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000546
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000523
AC:
25
AN:
47820
Hom.:
0
Cov.:
0
AF XY:
0.000575
AC XY:
6
AN XY:
10434
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
535
American (AMR)
AF:
0.000557
AC:
1
AN:
1795
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1098
East Asian (EAS)
AF:
0.00284
AC:
3
AN:
1055
South Asian (SAS)
AF:
0.000381
AC:
2
AN:
5245
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2923
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
177
European-Non Finnish (NFE)
AF:
0.000528
AC:
17
AN:
32212
Other (OTH)
AF:
0.000719
AC:
2
AN:
2780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.578
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000323
AC:
36
AN:
111407
Hom.:
0
Cov.:
23
AF XY:
0.000267
AC XY:
9
AN XY:
33657
show subpopulations
African (AFR)
AF:
0.0000652
AC:
2
AN:
30672
American (AMR)
AF:
0.0000957
AC:
1
AN:
10451
Ashkenazi Jewish (ASJ)
AF:
0.000380
AC:
1
AN:
2635
East Asian (EAS)
AF:
0.000284
AC:
1
AN:
3523
South Asian (SAS)
AF:
0.000374
AC:
1
AN:
2676
European-Finnish (FIN)
AF:
0.000168
AC:
1
AN:
5967
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000546
AC:
29
AN:
53070
Other (OTH)
AF:
0.00
AC:
0
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000329

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Pyruvate dehydrogenase E1-alpha deficiency Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.99
DANN
Benign
0.43
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376808450; hg19: chrX-19378500; API